Company Info
Since 2003, Cureline, Inc. has been dedicated to innovation in human tissue research . Using our team's scientific and clinical expertise, we have developed multi-site international collaborations and have implemented protocols for obtaining, handling and processing of human specimens worldwide. Since its inception, the primary focus of our company has been oncology, including solid tumors and hematologic malignancies. Every year our procurement network expands to new therapeutic areas and new countries and now we conduct projects in neurology, inflammation and metabolic and cardiovascular diseases.
To address the growing need for high-quality recently relocated to a newly renovated building in South San Francisco, CA that contains over 3,000 square feet of administrative space and a state-of the art laboratory facility.
Recently developed tissue acquisition and research protocols
- Primary cell lines from solid tumors, hematological cancers and normal tissues
- Viable epitope- specific cell fractions from blood and bone marrow
- Procurement of biospecimen sets (tissue biopsy, synovial fluid, PBMCs, serum, etc.) from patients with inflammatory diseases ( rheumatoid arthritis lupus, etc.)
